In the News
First-line antibiotic resistance may have increased 12% over 2 decades
More than 1 in 10 first-line antibiotic monotherapies for 4 common infections had treatment failure, an overall increase of 12% from 1991 to 2012, an industry-funded study found.
Foam, laser, surgery compared as varicose vein treatments
A comparison of 3 treatments for varicose veins found small differences in effectiveness and safety among them.
MKSAP Quiz: follow-up visit for urinary frequency
A 48-year-old man is evaluated during a follow-up visit for urinary frequency. He reports no hesitancy, urgency, dysuria, or change in urine color. He has not experienced fevers, chills, sweats, nausea, vomiting, diarrhea, or other gastrointestinal symptoms. He feels thirsty very often; drinking water and using lemon drops seem to help. He has a 33-pack-year history of smoking. He has hypertension, chronic kidney disease, and bipolar disorder. Medications are amlodipine, lisinopril, and lithium. He has tried other agents in place of lithium for his bipolar disorder, but none has controlled his symptoms as well as lithium. What is the most appropriate treatment intervention for this patient?
NSAID use may be associated with increased VTE risk
There may be a statistically significant increased risk of venous thromboembolism (VTE) among users of nonsteroidal anti-inflammatory drugs (NSAIDs), a meta-analysis found.
AHA statement describes prevention, treatment of the postthrombotic syndrome
A new scientific statement from the American Heart Association on the postthrombotic syndrome offers evidence-based prevention, diagnosis, and treatment strategies for inpatient and outpatient care.
Guideline released on management of non-ST-elevation acute coronary syndromes
The American Heart Association (AHA) and the American College of Cardiology (ACC) released the “2014 Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes” (NSTE-ACS) last week.
Hydrocodone rescheduled as of Oct. 6
As of Oct. 6, hydrocodone combination products (HCPs) will be rescheduled into Controlled Substance Schedule II. These products are currently Schedule III.
NCI trial looks to recruit patients with smoldering multiple myeloma
The National Cancer Institute is recruiting patients for a randomized phase III clinical trial to determine whether high-risk smoldering multiple myeloma (SMM) would benefit from early treatment.
Annals calls for Personae photographs in celebration of ACP's centennial
In recognition of the American College of Physicians' 100th anniversary, Annals of Internal Medicine is seeking photographs of internal medicine physicians to feature on each issue of the journal during 2015, ACP's centennial year.
ACP's High Value Care Primary Care Innovation Award presented
ACP sponsored an award given as part of Medstro and MedTech Boston's Innovation in Primary Care Competition for residents and physicians across the U.S. to submit innovative strategies to improve primary care on the American health care frontlines.
ACP course helps prescribers safely prescribe opioids, meet FDA requirements
The FDA requires a Risk Evaluation and Mitigation Strategy (REMS) for all brand and generic extended-release (ER) and long-acting (LA) opioid pain medicines to ensure that the benefits of prescribing a drug outweigh its risks for patients.
And the winner is …
ACP InternistWeekly has tallied the voting from its latest cartoon contest, where readers are invited to match wits against their peers to provide the most original and amusing caption.